Radiopharm Theranostics Ltd
ASX:RAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
Vulcan Energy Resources Ltd
ASX:VUL
|
AU |
|
P
|
Prime Medicine Inc
NASDAQ:PRME
|
US |
|
S
|
Suumaya Industries Ltd
NSE:SUULD
|
IN |
|
Newcrest Mining Ltd
ASX:NCM
|
AU |
|
Japan Tobacco Inc
TSE:2914
|
JP |
|
Accolade Inc
NASDAQ:ACCD
|
US |
|
Akeso Inc
OTC:AKESF
|
CN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RAD's stock price target?
Not Available
RAD doesn't have any price targets made by Wall Street professionals.
What is Radiopharm Theranostics Ltd's Revenue forecast?
Projected CAGR
142%
The compound annual growth rate of Radiopharm Theranostics Ltd's revenue for the next 3 years is 142%.